PRELUDE CAPITAL MANAGEMENT, LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 64 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$426,000
+161.3%
157,247
+84.1%
0.02%
+150.0%
Q2 2018$163,000
+3975.0%
85,412
+3458.8%
0.01%
Q2 2017$4,000
-97.7%
2,400
-95.5%
0.00%
-100.0%
Q1 2017$173,000
+133.8%
53,700
-1.5%
0.02%
+88.9%
Q4 2016$74,000
+252.4%
54,500
+300.7%
0.01%
+350.0%
Q3 2016$21,000
-12.5%
13,600
-25.7%
0.00%
-33.3%
Q2 2016$24,000
+100.0%
18,300
+698.1%
0.00%
+50.0%
Q1 2016$12,000
-70.0%
2,293
-55.2%
0.00%
-66.7%
Q4 2015$40,000
-46.7%
5,123
-25.8%
0.01%
-40.0%
Q2 2015$75,000
+66.7%
6,900
+115.6%
0.01%
+66.7%
Q1 2015$45,000
-75.8%
3,200
-70.9%
0.01%
-77.8%
Q4 2014$186,000
+675.0%
11,000
+450.0%
0.03%
+800.0%
Q1 2014$24,000
+242.9%
2,000
+300.0%
0.00%
+200.0%
Q4 2013$7,000
-58.8%
500
-50.0%
0.00%
-66.7%
Q3 2013$17,000
-89.6%
1,000
-90.0%
0.00%
-91.4%
Q2 2013$163,000
-95.2%
10,048
-85.8%
0.04%
-94.5%
Q1 2013$3,419,00070,5480.64%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
BVF INC/IL 15,232,268$29,094,0002.84%
EcoR1 Capital, LLC 412,000$787,0000.08%
PLATINUM INVESTMENT MANAGEMENT LTD 1,130,432$2,159,0000.05%
ESSEX INVESTMENT MANAGEMENT CO LLC 164,605$314,0000.04%
Clear Harbor Asset Management, LLC 95,630$183,0000.03%
ALGERT GLOBAL LLC 72,556$139,0000.03%
180 WEALTH ADVISORS, LLC 30,000$57,0000.03%
GSA CAPITAL PARTNERS LLP 289,854$554,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 85,412$163,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 459,000$877,0000.01%
View complete list of INFINITY PHARMACEUTICALS INC shareholders